Directory

>

Mohamed Genead Md

avatar

Mohamed Genead Md

Co-Founder & CEO | Aviceda Therapeutics

Cambridge, Massachusetts, United States

View contact details (it's free)

Mohamed Genead Md

Summary

Mohamed Genead Md is a visionary leader in the biotechnology sector, serving as the Co-Founder, CEO, and President of Aviceda Therapeutics. With a robust background as a retina specialist, he has dedicated over 15 years to pioneering innovative therapies aimed at curing blindness through advanced glyco-biology and gene therapy. His entrepreneurial journey is marked by successful ventures, substantial revenue generation exceeding $1 billion, and strategic partnerships with major pharmaceutical companies. Mohamed's expertise spans clinical development, regulatory compliance, and global drug development, making him a trusted advisor in the biotech ecosystem. He is passionate about leveraging technology to improve patient outcomes and has been instrumental in facilitating significant funding rounds for emerging biotech firms. His commitment to research is evident in his extensive publication record and ongoing contributions to the field of ophthalmology.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Mohamed Genead Md

Work Experience

company logo

Co-Founder & CEO at

Aviceda Therapeutics

February 2023 - Present

company logo

Co-Founder, CEO & President, Executive Board Director at

Aviceda Therapeutics

May 2018 - Present

💼

Principal & Founder at

Ophelia Bioconsulting LLC

January 2018 - Present

💼

GLG Council Member at

GERSON LEHRMAN GROUP (AUSTRALIA) PTY LTD

January 2015 - Present

💼

Strategic Corporate & Business Advisor Small/Med Cap Biotech at

Ophelia Bioconsulting LLC

April 2013 - Present

company logo

Chair Scientific Advisory Board at

Ocugen

February 2019 - July 2021

company logo

Scientific Advisor at

Atlas Venture

January 2017 - January 2019

company logo

Chief Medical Officer | Executive Vice-President at

GenSight Biologics

April 2017 - August 2018

company logo

Senior Medical Director, Ophthalmology/Retina Gene Therapy at

Biogen

January 2016 - January 2017

company logo

Global Executive Medical Director, Head of Ophthalmology/Retina Therapeutic Area at

Allegro Ophthalmics, LLC

January 2015 - May 2016

company logo

Global Medical Director | Ophthalmology | Retina Therapeutic Area at

AbbVie

January 2012 - January 2015

company logo

Ophthalmologist | Retina Specialist at

The University of Illinois At Chicago

January 2008 - January 2012

Logos provided by Logo.dev

Mohamed Genead Md

Education

University of Illinois at Chicago, Medical Retina Fellowship | Ophthalmologist | Retina Specialist

January 2008 - January 2009

Medical College of Wisconsin, Retina Reseach Fellowship

January 2004 - January 2008

Suez Canal University, Ophthalmology Surgical & Medical Residency

January 2001 - January 2004

Suez Canal University, Doctor Of Medicine - Md

January 1993 - January 2001

Frequently Asked Questions about Mohamed Genead Md

What is Mohamed Genead Md email address?

Mohamed Genead Md's primary email address is **************@xenonarc.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Mohamed Genead Md work for?

Mohamed Genead Md is a Co-Founder & CEO at Aviceda Therapeutics, a company specializing in Commercial physical research.

Where Mohamed Genead Md graduated from?

Mohamed Genead Md holds a degree in Retina & Herediatry Retinal Degeneration from University of Illinois at Chicago.

How can I directly contact Mohamed Genead Md?

To contact Mohamed Genead Md directly, you can use the email address **************@xenonarc.com. Complete contact information is available upon registration with Muraena.

Who is Mohamed Genead Md?

Mohamed Genead Md is a visionary leader in the biotechnology sector, serving as the Co-Founder, CEO, and President of Aviceda Therapeutics. With a robust background as a retina specialist, he has dedicated over 15 years to pioneering innovative therapies aimed at curing blindness through advanced glyco-biology and gene therapy. His entrepreneurial journey is marked by successful ventures, substantial revenue generation exceeding $1 billion, and strategic partnerships with major pharmaceutical companies. Mohamed's expertise spans clinical development, regulatory compliance, and global drug development, making him a trusted advisor in the biotech ecosystem. He is passionate about leveraging technology to improve patient outcomes and has been instrumental in facilitating significant funding rounds for emerging biotech firms. His commitment to research is evident in his extensive publication record and ongoing contributions to the field of ophthalmology.

Mohamed`s contact details

mail

**************@xenonarc.com

**************@glg.it

*******@avicedarx.com

*******@palleonpharma.com

Colleagues

avatar
Anitha Krishnan

Executive Director-Research

avatar
Michael Tolentino

Clinical Associate Professor

avatar
Derek Kunimoto

General Manager

avatar
David Callanan

Chief Medical Officer

View Contact details (it's free)
Request Profile Removal